This is a working overview of melanocortin receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-02-22 and is reviewed periodically as new material appears.
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilised material may be hygroscopic |
| Solubility class | Soluble in water, DMSO and DMF | Dilution into aqueous buffer can cause precipitation |
| Storage of solid | Minus 20 degrees C, desiccated, dark | Aliquot to limit repeated opening of the vial |
| Storage of solution | Minus 20 to minus 80 degrees C, aliquoted | Avoid repeated freeze-thaw cycles |
| Identity method | Reversed-phase HPLC with mass spectrometry | Retention time and mass are checked together |
Regulatory treatment of this peptide varies by country. It holds no marketing authorization as a medicine in the United States, the European Union, or most other jurisdictions. Some countries classify products containing it as prescription-only or unlicensed medicines, which restricts lawful supply. Authorities have issued public notices warning that unregulated products may contain undeclared or incorrect ingredients. The molecule also appears on prohibited lists for competitive sport. These measures address supply oversight rather than any approved therapeutic role.
Published research on the compound remains limited. Much of the human data comes from small, early-stage studies rather than large controlled trials, and several questions about effects and variability between individuals remain open. Investigators have examined receptor activity, pigment pathways, and related physiological responses in laboratory and animal models. Findings from those models do not automatically translate to human outcomes. Reviews frequently note the scarcity of rigorous clinical evidence and call for better-characterized study material.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
=== Other uses === Ethyl carbamate was primarily an intermediate in the preparation of amino resins, that were in turn used as crosslinking agents for permanent-press textile treatments to create "wash-and-wear" fabrics. Other uses included as solvent or intermediates in the manufacture of pesticides, cosmetics and pharmaceuticals.
The report concluded that a final determination of the origin was unlikely without cooperation from the Chinese government, saying their prior lack of transparency "reflect[ed] in part China's government's own uncertainty about where an investigation could lead, as well as its frustration that the international community is using the issue to exert political pressure on China." Chinese foreign ministry spokesman Wang Wenbin said that the US intelligence report was "unscientific and has no credibility". On 23 May 2021, The Wall Street Journal reported that a previously undisclosed US intelligence report stated that three researchers from the Wuhan Institute of Virology became ill enough in November 2019 to seek hospital care. The report did not specify what the illness was. Officials familiar with the intelligence differed as to the strength to which it corroborates the hypothesis that the virus responsible for COVID-19 was leaked from the WIV. The WSJ report notes that it is not unusual for people in China to go to the hospital with uncomplicated influenza or common cold symptoms. Yuan Zhiming, director of the WIV's Wuhan National Biosafety Laboratory, responded in the Global Times, a Chinese state media outlet, that the "claims are groundless". Marion Koopmans, a member of the WHO study team, described the number of flu-like illnesses at the WIV in 2019 as "completely normal". Workers at the WIV must provide yearly serum samples. WIV virologist Shi Zhengli said in 2020 that, based on an evaluation of those serum samples, all staff tested negative for COVID-19 antibodies.
Since the turn of the millennium, the Russian Armed Forces have been issued the Individual Food Rations (Russian: Индивидуальный рацион питания/ИРП, romanized: Individual'nyi Ratsion Pitaniya (IRP)), a new self-contained ration, containing the whole daily food intake for an individual soldier in the field. However, in its most frequent form it is not dietary complete, and is intended only as a stop-gap measure to be issued until the normal supply lines (with their field kitchens) are established and the hot food delivery started, to be issued for no more than six days straight. The Ministry of Defence does not strictly prescribe the contents of the ration, only some basic packaging and inventory requirements, so every producer issues their own version. Most commonly it is packaged into a sturdy plastic blister box (nicknamed "The Frog" in the field for its olive-green color), or plastic-sealed cardboard box that contains five to six entrees in laminated foil cans or retort pouches, four to six pack of crackers or preserved bread, two to three dessert items in form of a spread or fruit bar, four beverage concentrate pouches, some seasonings (salt, pepper, sugar, ketchup), and various sundry items like sanitizing wipes/paper towels, spoons, can opener, four hexamine fuel tablets, folding heater, matches and water purifier tablets.
== External links == 1920 map showing German territory's changes, including marked area for the East Prussia plebiscite Mapa powiatów malborskiego i kwidzynskiego z naniesionymi przedstawieniami wyników plebiscytu sporządzona 11 VII 1920 Map of interwar Poland; shows plebiscite areas Map of interwar Poland; shows plebiscite areas (in color) (in Polish) Małe ząbkowane – czyli rzecz o kwidzynskich znaczkach plebiscytowych i nie tylko (in Polish) Karsten, Carl (1922). "Allenstein-Marienwerder" . Encyclopædia Britannica (12th ed.).
Sources: en.wikipedia.org
=== Geophysics === Beneath the Earth's mantle lies the core, which is made up of two parts: the solid inner core and the liquid outer core. Both contain significant quantities of iron. The liquid outer core moves in the presence of the magnetic field, and eddies are generated within it due to the Coriolis effect. These eddies develop a magnetic field that boosts Earth's original magnetic field, a self-sustaining process known as the geomagnetic dynamo.
Russia launched 16 missiles and 13 drones at energy infrastructure across Ukraine. Two energy workers in Zaporizhzhia Oblast were wounded. In Lviv Oblast a missile hit an energy facility, starting a fire. In Ivano-Frankivsk one of the buildings of Ivano-Frankivsk National Technical University of Oil and Gas was semi-destroyed and a kindergarten was damaged. Explosions were reported in Volyn and Vinnytsia Oblasts. Twelve missiles and all drones were shot down, according to the Ukrainian Air Force. Russian media reported that a Pantsir S-1 anti-aircraft missile system was struck in a Ukrainian air attack in Belgorod Oblast. Three people were killed in Russian airstrikes in Kharkiv.
Omics.org Archived 2014-01-02 at the Wayback Machine Omics terms and concepts home page. Probably the first omics web page created. List of omics Archived 2015-07-09 at the Wayback Machine, including references/origins. Maintained by the (CHI) Cambridge Health Institute.
Sources: en.wikipedia.org
== Projects == Oncocheck ONCOCHECK is a set of clinical studies conducted by Life Length during 2017. The aim of the project was the clinical validation of telomere-associated variables (TAVs) as cancer biomarkers. It involved more than 1,200 adults and 300 children suffering from one of multiple existing types of cancer, including breast, prostate, lung, and leukemia cancers, among others. ONCOCHECK received funding from the European Union's Horizon 2020 research and innovation program. With more than 7,000 peer-reviewed scientific and clinical publications, telomere length measurement has established itself as a biomarker in cancer diagnosis and prognosis. This project has the invaluable support of some of the most important hospitals in Spain such as "University Hospital 12 de octubre", "University Hospital Puerta de Hierro", "University Hospital Niño Jesús", "Vall d'Hebron Hospital", and "Centro Integral Oncológico Clara Campal (CIOCC)". Within the ONCOCHECK project, Life Length is also conducting studies in advanced solid tumors and chronic lymphocytic leukemia (CLL). The results of the ONCOCHECK project have enabled Life Length to develop new applications in oncology . Prostate cancer diagnosis product Telomeres as cancer biomarkers: Tumor cells work differently from normal cells. As a cell becomes cancerous, it divides more frequently, and its telomeres shorten faster. Cancer cells avoid senescence/death and instead become immortal with the ability to replicate indefinitely, even when telomeres are short.
== Science and mathematics == Semi-infinite programming, a type of mathematical optimization problem Spectral induced polarisation, in geophysics Stable-isotope probing, used in molecular biology Statistically improbable phrases, a system used to find unique phrases for use as keywords Stochastic Information Packet, in probability management, a representation of the probability distribution of a variable Strongly implicit procedure, an algorithm for solving a sparse linear system of equations Structure-inducing probes, a peptide synthesis to stabilize long peptides
=== Motility and chemotaxis === The vertical motility of neutrophils in capillary tubes is stimulated by tuftsin, stimulation is inhibited by Thr-Lys-Pro-Pro-Arg. The tuftsin analogue Thr-Pro-Lys-Arg failed to show stimulation.
Sources: en.wikipedia.org
Purity is normally stated as an area percentage from high-performance liquid chromatography, for example ninety-five or ninety-eight percent. That figure describes the proportion of ultraviolet-absorbing material eluting as the main peak. It says nothing about water content, counterions, residual solvents or mass fraction of the peptide itself.
Peptides are commonly isolated as acetate or trifluoroacetate salts, and the counterion contributes to total mass. Two vials with identical peptide content can therefore differ in weight and in measured response. Residual trifluoroacetate is also relevant in cell-based work because it can influence membrane behaviour.
Degradation products are often closely related to the parent molecule, making them hard to resolve with a single method. Counterion variability adds a further source of scatter between laboratories. Because no pharmacopoeial monograph exists for melanotan-2, groups rely on method-specific validation rather than a shared reference standard.
No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.